Euclidean Capital LLC Revolution Medicines, Inc. Transaction History
Euclidean Capital LLC
- $779 Million
- Q1 2024
Shares
2 transactions
Others Institutions Holding RVMD
# of Institutions
219Shares Held
153MCall Options Held
321KPut Options Held
111K-
Vanguard Group Inc Valley Forge, PA14.8MShares$573 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA14.7MShares$571 Million0.09% of portfolio
-
Black Rock Inc. New York, NY12.3MShares$478 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY7.55MShares$293 Million3.08% of portfolio
-
Farallon Capital Management LLC San Francisco, CA7.51MShares$291 Million1.13% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.4B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...